This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Chris Slavinsky
Vice President, Center for External Innovation at Takeda Pharmaceutical Co., Ltd.


Chris Slavinsky is Vice President, Takeda Pharmaceuticals’ Center for External Innovation, where he leads business development transactions across therapeutic areas, focusing on gastroenterology and, more broadly, asset externalization. Prior to joining Takeda, Chris held positions of increasing responsibility in Pfizer’s Legal Division, with a focus on complex transactions, post-acquisition integration and alliance management, and issues related to product development, manufacture and commercialization. Chris holds a JD from the Washington University in St Louis School of Law, an MS in biochemistry and molecular biology from Thomas Jefferson University (Philadelphia), and a BS in biochemistry from the State University of New York at Stony Brook.

Agenda Sessions

  • How is Pharma Thinking About Out-licensing?